U.S. to pay Sanofi and GSK $2.1 billion for Covid-19 vaccine - STAT

U.S. to pay Sanofi and GSK $2.1 billion for Covid-19 vaccine - STAT

Sanofi and GSK land $2.1 billion deal with U.S. for Covid-19 vaccine development and 100 million doses

By MATTHEW HERPER

KRISTOFFER TRIPPLAAR/SIPA VIA AP IMAGES

Operation Warp Speed will provide up to $2.1 billion to Sanofi and GlaxoSmithKline to fund development and manufacturing of the companies' Covid-19 vaccine.

READ MORE